ClinicalTrials.Veeva

Menu

Recurrence Rate of Minimally Invasive Endoscopic Treatment of Internal Hemorrhoids

S

Shenzhen Hospital of Southern Medical University

Status

Not yet enrolling

Conditions

Internal Hemorrhoid

Treatments

Device: Tie up device

Study type

Observational

Funder types

Other

Identifiers

NCT06250140
ShenzhenH

Details and patient eligibility

About

2.1 Main objective: To observe the short-term and long-term recurrence rates of various endoscopic minimally invasive treatment methods for internal hemorrhoids and different time points of endoscopic minimally invasive treatment for internal hemorrhoids in patients with grade I-III internal hemorrhoids

2.2 Secondary objective: To observe the safety and efficacy of endoscopic minimally invasive treatment of internal hemorrhoids

Enrollment

900 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Age ≥18 years old, both sexes

    2, grade I-III internal hemorrhoids with symptoms related to internal hemorrhoids

    1. The purpose and adverse consequences of endoscopic minimally invasive treatment of internal hemorrhoids have been fully understood before surgery, and the informed consent for endoscopic minimally invasive treatment of internal hemorrhoids has been signed

Exclusion criteria

    1. Patients with contraindications to endoscopic minimally invasive treatment (1) grade IV internal hemorrhoids, mixed hemorrhoids and external hemorrhoids; (2) I-III

Degree of internal hemorrhoids with incarceration, thrombosis, erosion, infection, etc. (3) patients with severe systemic diseases could not tolerate endoscopic treatment; (4) accompanied by crissum infectious disease, anal fistula, and inflammatory bowel disease activity, etc.; (5) in menstrual period, pregnancy and puerperium, (6) patients with sclerotherapy allergy; (7) function of blood coagulation disorder or are using anticoagulant drugs.

  1. Patients with a history of allergy to narcotic drugs

  2. Patients who were deemed by the investigator to be ineligible for participation in the trial

Trial design

900 participants in 3 patient groups

Internal hemorrhoid ligation group
Description:
Endoscopic internal hemorrhoid ligation
Treatment:
Device: Tie up device
Hemorrhoids injection group
Description:
Endoscopic hemorrhoid injection was performed
Treatment:
Device: Tie up device
Internal hemorrhoids combined treatment group
Description:
Lines of endoscopic hemorrhoids and internal ligation under endoscope to injection
Treatment:
Device: Tie up device

Trial documents
1

Trial contacts and locations

0

Loading...

Central trial contact

Zheng Zewei Zewei Zheng, Professor; Ying Zhu Ying Zhu, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems